Endovia Health Sciences (EDVA) Net Cash Flow (QoQ) (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Net Cash Flow (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.08% |
| Mar 31, 2026 | 1,019.72% |
| Dec 31, 2025 | -106.54% |
| Sep 30, 2025 | 40.81% |
| Jun 30, 2025 | 378.03% |
| Mar 31, 2025 | -121.83% |
| Dec 31, 2024 | -34.17% |
| Sep 30, 2024 | 5,573.01% |
| Jun 30, 2024 | 98.14% |
| Mar 31, 2024 | -222.53% |
| Dec 31, 2023 | 134.91% |
| Sep 30, 2023 | 31.81% |
| Jun 30, 2023 | 46.30% |
| Mar 31, 2023 | -221.27% |
| Dec 31, 2022 | 217.37% |
| Sep 30, 2022 | 60.52% |
| Jun 30, 2022 | -199.39% |
| Mar 31, 2022 | 211.58% |
| Dec 31, 2021 | 4.09% |
| Sep 30, 2021 | -135.00% |